Terapia de la encefalitis rábica

Alan C. Jackson, .

Descargas

La descarga de datos todavía no está disponible.
  • Alan C. Jackson Departments of Internal Medicine (Neurology) and of Medical Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada
    Health Sciences Centre, GF-543, 820 Sherbrook Street, Winnipeg, Manitoba R3A 1R9 Canada. Telephone: 1-204 787-1578; fax: 1-204-787-1486.

Referencias bibliográficas

1. World Health Organization. WHO expert consultation on rabies: first report. Geneva: WHO; 2005.
2. Jackson AC, Warrell MJ, Rupprecht CE, Ertl HC, Dietzschold B, O’Reilly M, et al. Management of rabies in humans. Clin Infect Dis. 2003;36:60-3.
3. Jackson AC. Human disease. In: Jackson AC, Wunner WH, editors. Rabies. London: Elsevier Academic Press; 2007. p. 309-40.
4. Willoughby RE Jr, Tieves KS, Hoffman GM, Ghanayem NS, Amlie-Lefond CM, Schwabe MJ, et al. Survival after treatment of rabies with induction of coma. N Engl J Med. 2005;352:2508-14.
5. Merigan TC, Baer GM, Winkler WG, Bernard KW, Gibert CG, Chany C, et al. Human leukocyte interferon administration to patients with symptomatic and suspected rabies. Ann Neurol. 1984;16:82-7.
6. Kureishi A, Xu LZ, Wu H, Stiver HG. Rabies in China: recommendations for control. Bull World Health Organ. 1992; 70:443-50.
7. Warrell MJ, White NJ, Looareesuwan S, Phillips RE, Suntharasamai P, Chanthavanich P, et al. Failure of interferon alfa and tribavirin in rabies encephalitis. Br Med J. 1989;299:830-3.
8. Hemachudha T, Sunsaneewitayakul B, Mitrabhakdi E, Suankratay C, Laothamathas J, Wacharapluesadee S, et al. Paralytic complications following intravenous rabies immune globulin treatment in a patient with furious rabies. Int J Infect Dis. 2003;7:76-7.
9. Emmons RW, Leonard LL, DeGenaro F Jr, Protas ES, Bazeley PL, Giammona ST, et al. A case of human rabies with prolonged survival. Intervirology. 1973;1:60-72.
10. Hattwick MA, Corey L, Creech WB. Clinical use of human globulin immune to rabies virus. J Infect Dis. 1976;133 (Suppl):A266-72.
11. Basgoz N. Case 21-1998: rabies. N Engl J Med. 1999;340:64-5.
12. Superti F, Seganti L, Pana A, Orsi N. Effect of amantadine on rhabdovirus infection. Drugs Exp Clin Res. 1985;11:69-74.
13. Hu WT, Willoughby RE Jr, Dhonau H, Mack KJ. Long-term follow-up after treatment of rabies by induction of coma. N Engl J Med. 2007;357:945-6.
14. Lafon M. Bat rabies--the Achilles heel of a viral killer? Lancet. 2005;366:876-7.
15. Hattwick MA, Weis TT, Stechschulte CJ, Baer GM, Gregg MB. Recovery from rabies: a case report. Ann Intern Med. 1972;76:931-42.
16. Ministerio da Saude in Brazil. Rabies, human survival, bat-Brazil: (Pernambuco). ProMED-mail. 2008; 20081114.3599. [Accessed: May 19, 2009] Available at: http://www.promedmail.org/pls/otn/f?p=2400:1001:57555::::F2400_P1001_BACK_PAGE,F2400_P1001_ARCHIVE_NUMBER,F2400_P1001_USE_ARCHIVE:1001,20081114.3599,Y
17. Lafon M. Immunology. In: Jackson AC, Wunner WH, editors. Rabies. London: Elsevier Academic Press; 2007. p. 489-504.
18. Jackson AC. Recovery from rabies. N Engl J Med. 2005;352:2549-50.
19. Krishnamurthy KB, Drislane FW. Depth of EEG suppression and outcome in barbiturate anesthetic treatment for refractory status epilepticus. Epilepsia. 1999;40:759-62.
20. Bassin S, Smith TL, Bleck TP. Clinical review: status epilepticus. Crit Care. 2002;6:137-42.
21. Nevander G, Ingvar M, Auer R, Siesjo BK. Status epilepticus in well-oxygenated rats causes neuronal necrosis. Ann Neurol. 1985;18:281-90.
22. Meldrum BS, Brierley JB. Prolonged epileptic seizures in primates. Ischemic cell change and its relation to ictal physiological events. Arch Neurol. 1973;28:10-7.
23. Lockhart BP, Tordo N, Tsiang H. Inhibition of rabies virus transcription in rat cortical neurons with the dissociative anesthetic ketamine. Antimicrob Agents Chemother. 1992;36:1750-5.
24. Lockhart BP, Tsiang H, Ceccaldi PE, Guillemer S. Ketamine-mediated inhibition of rabies virus infection in vitro and in rat brain. Antivir Chem Chemother. 1991;2:9-15.
25. Weli SC, Scott CA, Ward CA, Jackson AC. Rabies virus infection of primary neuronal cultures and adult mice: failure to demonstrate evidence of excitotoxicity. J Virol. 2006;80:10270-3.
26. Cheng YD, Al-Khoury L, Zivin JA. Neuroprotection for ischemic stroke: two decades of success and failure. NeuroRx. 2004;1:36-45.
27. Ginsberg MD. Current status of neuroprotection for cerebral ischemia: synoptic overview. Stroke. 2009;40(Suppl 3):S111-4.
28. Willoughby RE, Roy-Burman A, Martin KW, Christensen JC, Westenkirschner DF, Fleck JD, et al. Generalised cranial artery spasm in human rabies. Dev Biol (Basel). 2008;131:367-75.
29. McDermid RC, Saxinger L, Lee B, Johnstone J, Noel Gibney RT, Johnson M, et al. Human rabies encephalitis following bat exposure: failure of therapeutic coma. Can Med Assoc J. 2008;178:557-61.
30. Wilde H, Hemachudha T, Jackson AC. Viewpoint: management of human rabies. Trans R Soc Trop Med Hyg. 2008;102:979-82.
31. Rubin J, David D, Willoughby RE Jr, Rupprecht CE, Garcia C, Guarda DC, et al. Applying the Milwaukee protocol to treat canine rabies in Equatorial Guinea. Scand J Infect Dis. 2009;41:372-5.
32. Daily Telegraph Online. Rabies, human - United Kingdom (04): (Northern Ireland) ex South Africa. ProMED-mail. 2009; 20090107.0065. [Accessed: May 19, 2009]. Available at: http://www.promedmail.org/pls/otn/f?p=2400:1202:19224::NO::F2400_P1202_CHECK_DISPLAY,F2400_P1202_PUB_MAIL_ID:X,75493
Cómo citar
1.
Jackson AC. Terapia de la encefalitis rábica. biomedica [Internet]. 1 [citado 19 de septiembre de 2021];29(2):169-76. Disponible en: https://revistabiomedica.org/index.php/biomedica/article/view/18
Sección
Editorial